← Every company
Vaxcyte Inc Patents
What Vaxcyte Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
PCVX on carbonthat →Filings on file
10
Granted
0
Still pending
10
Filed under
2 names
10 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| PURIFICATION OF CAPSULAR POLYSACCHARIDESB01D 39/06, C08B 37/0003, B01D2311/2697, B01D2325/0283, B01D2315/17, B01D 61/146, B01D 15/125, B01D 15/327, B01D 15/38, B01D 15/3847, B01D 39/04, B01D 39/1692, B01D 39/2055, B01D 39/2065, B01D 61/58, B01D 71/022, B01D 71/68, B01D2221/10, B01D2257/91, B01D2315/10, C12P 19/04, C08L 5/00, C08L 89/00Filed as Vaxcyte, Inc.2025-09-30Peter T. Davey | pending |
| AEROTOLERANT BACTERIA FERMENTATIONC12N 1/20, C12R2001/46, A61K 39/00, C12N2500/02, C12P 19/04Filed as Vaxcyte, Inc.2025-09-17Peter T. Davey | pending |
| CARRIER-PROTEIN POLYSACCHARIDE CONJUGATION METHODSC07B 37/10, A61K 47/62, A61K 47/545, C07K 1/1077, C07K 19/00Filed as Vaxcyte, Inc.2025-02-12Jeffery C. Fairman | pending |
| SHIGELLA VACCINE COMPOSITIONSFiled as VAXCYTE, INC.2024-10-22JEFF FAIRMAN | pending |
| CHLAMYDIA VACCINE COMPOSITIONSFiled as VAXCYTE, INC.2024-10-03JAMES ROZZELLE | pending |
| POLYPEPTIDE-ANTIGEN CONJUGATES WITH NON-NATURAL AMINO ACIDSA61K 47/6415, A61K 39/092, A61K 39/385, A61K 47/646, A61P 37/00, A61P 31/04, A61P 29/00, A61K 39/0208, A61K 39/095, A61K2039/575, A61K2039/6037, A61K2039/6087, A61K2039/627, A61K2039/70, C07K 17/02Filed as Vaxcyte, Inc.2024-04-16Jeffery FAIRMAN | pending |
| PURIFICATION OF CAPSULAR POLYSACCHARIDESFiled as VAXCYTE, INC.2024-04-03PETER T. DAVEY | pending |
| AEROTOLERANT BACTERIA FERMENTATIONFiled as VAXCYTE, INC.2024-03-15PETER T. DAVEY | pending |
| STABILIZATION OF ADJUVANTED VACCINE COMPOSITIONS AND THEIR USEA61K 39/00, A61K 39/092, A61K 39/095, A61K 39/102, A61K 39/39, A61K 47/02, A61K2039/55505, A61K2039/6031, A61K2039/6087Filed as Vaxcyte, Inc.2024-02-29Christopher Iain GRAINGER | pending |
| CONJUGATED VACCINE CARRIER PROTEINSA61K 39/385, A61P 31/04, A61K 38/00, A61K 39/092, A61K2039/6037, A61K2039/627, A61K2039/70, C07K 14/001, C07K 14/285, C07K 14/33, C07K 14/34Filed as Vaxcyte, Inc.2024-02-06Jeffery C. FAIRMAN | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on PCVX
Company overviewEverything on PCVX in one place, with the price.SEC filingsWhat PCVX's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat PCVX's own officers and directors buy and sell.Planned salesSales PCVX insiders have filed notice of.Executive payWhat PCVX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in PCVX.Funds holding itWhich funds and ETFs hold PCVX, and how big a bet.LobbyingWhat PCVX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on PCVX's account, and who they worked for.